PH sensitive alginate-chitosan hydrogel beads for carvedilol delivery

Pharmaceutical Development and Technology

Volumn 16, Issue 1, 2011, Pages 22-28

  Meng, Xun ^a   Li, Ping ^a   Wei, Qin ^a   Zhang, Hai Xuan ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Carvedilol; Chitosan; Delivery properties; PH sensitive hydrogel; Swelling characteristics

Indexed keywords

ALGINIC ACID; CARVEDILOL; CHITOSAN;

ALKALINITY; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROGEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ADRENERGIC BETA-ANTAGONISTS; ALGINATES; CARBAZOLES; CHITOSAN; DRUG CARRIERS; GASTRIC JUICE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGELS; HYDROGEN-ION CONCENTRATION; INTESTINAL SECRETIONS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MODELS, BIOLOGICAL; PROPANOLAMINES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 78651070547     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450903479947     Document Type: Article

References (29)

1. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review. J Control Release 2006;114(1):1-14.
2. Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104(12):6017-6084.
3. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100(1):5-28.
4. Liu LS, Fishman ML, Kost J, Hicks KB. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 2003;24(19):3333-3343.
5. Mi FL, Tan YC, Liang HF, Sung HW. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 2002;23(1):181-191.
6. Bristow MR, Larrabee P, Muller-Beckmann B, Minobe W, Roden R, Skerl L, et al. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin Investig 1992;70(suppl. 1): S105-113.
7. Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 1995;16(suppl. F):38-42.
8. Nichols AJ, Gellai M, Ruffolo RR Jr. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol 1991;5(1):25-38.
9. McTavish D, Campoli-Richards D, Sorkin, EM. Carvedilol: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1993;45:232-258.
10. Agnihotri SA, Aminabhavi TM. Development of novel interpenetrating network gellan gum-poly(vinyl alcohol) hydrogel microspheres for the controlled release of carvedilol. Drug Dev Ind Pharm 2005;31(6):491-503.
11. Li P, Dai YN, Zhang JP, Wang AQ, Wei Q. Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci 2008;4(3):221-228.
12. Li P, Zhang JP, Wang AQ. A novel N-Succinyl chitosan-graft- Polyacrylamide/ Attapulgite composite hydrogel prepared through inverse suspension polymerization. Macromol Mater Engin 2007;292(8):962-969.
13. Kiliçarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm 2003;252(1-2):99-109.
14. Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginatechitosan beads. Int J Pharm 2006;323(1-2):34-42.
15. Lin YH, Liang HF, Chung CK, Sung HW. Physically crosslinked alginate /N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 2005; 26(14):2105-2113.
16. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm 2007;65(2): 215-232.
17. Chen SC, Wu YC, Mi FL, Sung HW. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Rel 2004;96(2):285-300.
18. Mundargi RC, Patil SA, Aminabhavi TM. Evaluation of acrylamide- grafted-xanthan gum copolymer matrix tablets for oral controlled delivery of antihypertensive drugs. Carbohydrate Polymers 2007;69(1):130-141.
19. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54(1):3-12.
20. Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate- chitosan beads. Int J Pharm 2006;323(1-2):34-42.
21. Sarmento B, Ribeiro A, Veiga F, Ferreira D. Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatogr 2006;20:898-903.
22. Lin WC, Yu DG, Yang MC. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate:swelling kinetics and drug delivery properties. Colloids Surfaces B:Biointerfaces 2005;44(2-3):143-151.
23. George M, Abraham TE. pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. Int J Pharm 2007;335(1-2):123-129.
24. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. A novel pH sensitive N-Succinyl Chitosan/lginate hydrogel bead for nifedipine delivery. Biopharm Drug Dispos 2008;29(3): 173-184.
25. Dai YN, Li P, Zhang JP, Wang AQ, Wei Q. Swelling characteristics and drug delivery properties of nifedipine-loaded ph sensitive alginate-chitosan hydrogel beads. J Biomed Mater Res 2008;86B(2):493-500.
26. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60(4):110-111.
27. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rel 1987;5(1):37-42.
28. Takka S, Ocak OH, Acartürk F. Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies. Eur J Pharm Biopharm 1998;6(3): 241-246.
29. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48(2-3):139-157.